Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis
- PMID: 27873565
- PMCID: PMC9507688
- DOI: 10.1017/S0950268816002624
Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis
Abstract
Achromobacter spp. are opportunistic pathogens increasingly recovered from adult patients with cystic fibrosis (CF). We report the characterization of 122 Achromobacter spp. isolates recovered from 39 CF patients by multilocus sequence typing, virulence traits, and susceptibility to antimicrobials. Two species, A. xylosoxidans (77%) and A. ruhlandii (23%) were identified. All isolates showed a similar biofilm formation ability, and a positive swimming phenotype. By contrast, 4·3% and 44·4% of A. xylosoxidans and A. ruhlandii, respectively, exhibited a negative swarming phenotype, making the swimming and swarming abilities of A. xylosoxidans significantly higher than those of A. ruhlandii. A. xylosoxidans isolates from an outbreak clone also exhibited significantly higher motility. Both species were generally susceptible to ceftazidime, ciprofloxacin, imipenem and trimethoprim/sulphamethoxazole and there was no significant difference in susceptibility between isolates from chronic or sporadic infection. However, A. xylosoxidans isolates from chronic and sporadic cases were significantly more resistant to imipenem and ceftazidime than isolates of the outbreak clone.
Keywords: Achromobacter; clinical microbiology; cystic fibrosis.
Conflict of interest statement
None.
Figures
References
-
- Ciofu O, Hansen CR, Høiby N. Respiratory bacterial infections in cystic fibrosis. Current Opinion in Pulmonary Medicine 2013; 19: 251–258. - PubMed
-
- Tan K, et al. Alcaligenes infection in cystic fibrosis. Pediatric Pulmonology 2002; 34: 101–104. - PubMed
-
- De Baets F, et al. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance. Journal of Cystic Fibrosis 2007; 6: 75–78. - PubMed
-
- Ronne-Hansen CR, et al. Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. Journal of Cystic Fibrosis 2006; 5: 245–251. - PubMed
-
- Ronne-Hansen CR, et al. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. Journal of Cystic Fibrosis 2010; 9: 51–58. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
